Identification of biomarkers based on ubiquitin-correlated genes for predicting immune profile and drug sensitivity in lung adenocarcinoma
This study is the first to systematically integrate the ubiquitin pathway with multi-omics data, constructing a robust risk model for LUAD prognosis and immune characteristics, providing a theoretical reference for future exploration of potential biomarkers for LUAD patients' diagnosis.
Authors
- Zhenfa Zhang (ORCID: https://orcid.org/0000-0002-9627-2590)
- Wei Tian (ORCID: https://orcid.org/0000-0003-2398-5968)
- Chen Chen (ORCID: https://orcid.org/0000-0003-2104-534X)
- Hailin Liu (ORCID: https://orcid.org/0000-0003-2807-3781)
- Changli Wang (ORCID: https://orcid.org/0000-0002-7665-8314)
- Yue Li
Institutions
- Tianjin University of Traditional Chinese Medicine (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-08-15
- DOI
- https://doi.org/10.3389/fphar.2025.1646396
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00